| Application no. and date | 03789744.4 (espacenet) (Federated) (European Patent Register), 20031114 | | Patent/reg. no. and date | DK/EP 1565201, 20181031 | | Publication date | 20050824 | | Priority no. and date | US 427654 P, 20021118, US 485694 P, 20030708, US 495048 P, 20030813, US 496483 P, 20030819 | | EP pub. no. and date |
EP 1565201 20050824 | | Effective date | | | Applicant/owner | Vicuron Pharmaceuticals LLC, 5 Giralda Farms
Madison, NJ 07940, US | | Applicant ref. no. | P67251DK01 | | Inventor | STOGNIEW, Martin, 1870 Ferguson Lane
Blue Bell, PA 19422, US,
CAVALERI, Marco, Via G. Ferrari, 9
I-21047 Saronno, IT,
HENKEL, Timothy, 1113 Cymry Drive
Berwyn, PA 19312, US,
JABES, Daniela, Via Volta, 4
I-22070 Cassina Rizzardi, IT,
MALABARBA, Adriano, Via Roma, 5
I-20082 Buccinasco, IT,
MOSCONI, Giorgio, Koorman Comm. Woodview, Apt. 3307,
Lancaster Ave.
Malvern, PA 19355, US,
WHITE, Richard, J., 6363 Christie Avenue, Apt. 1917
Emeryville, CA 94608, US | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | A61K 38/14 (2006.01) , A61P 31/04 (2006.01) | | Title | FREMGANGSMÅDER TIL AT ADMINISTRERE DALBAVANCIN TIL BEHANDLING AF BAKTERIEINFEKTIONER | | Int. application no. | US2003036127 | | Int. publication no. | WO2004045636 | | Related patent (certificate) | | | Status | Udløbet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
